Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7935)
All Articles published online
|
Publishing Process of This Article
|
Jun 28, 2017 (publication date) through Nov 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Cidon EU. Systemic treatment of hepatocellular carcinoma: Past, present and future. World J Hepatol 2017; 9(18): 797-807 [PMID: 28706578 DOI: 10.4254/wjh.v9.i18.797] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v9/i18/797.htm |
| Number | Citing Articles |
| 1 |
Bijay Dhungel, Charmaine A. Ramlogan-Steel, Christopher J. Layton, Jason C. Steel. MicroRNA199a-Based Post-transcriptional Detargeting of Gene Vectors for Hepatocellular Carcinoma. Molecular Therapy - Nucleic Acids 2018; 13: 78 doi: 10.1016/j.omtn.2018.08.016
|
| 2 |
Khalil Hajiasgharzadeh, Mohammad Hossein Somi, Saeed Sadigh-Eteghad, Ahad Mokhtarzadeh, Dariush Shanehbandi, Behzad Mansoori, Ali Mohammadi, Mohammad Amin Doustvandi, Behzad Baradaran. The dual role of alpha7 nicotinic acetylcholine receptor in inflammation-associated gastrointestinal cancers. Heliyon 2020; 6(3): e03611 doi: 10.1016/j.heliyon.2020.e03611
|
| 3 |
Andreas Koulouris, Christos Tsagkaris, Vasiliki Spyrou, Eleni Pappa, Aikaterini Troullinou, Michail Nikolaou. Hepatocellular Carcinoma: An Overview of the Changing Landscape of Treatment Options. Journal of Hepatocellular Carcinoma 2021; : 387 doi: 10.2147/JHC.S300182
|
| 4 |
Mei Guo. Cellular senescence and liver disease: Mechanisms and therapeutic strategies. Biomedicine & Pharmacotherapy 2017; 96: 1527 doi: 10.1016/j.biopha.2017.11.075
|
| 5 |
Yan Wang, Ping Zhang, Mei Yuan, Xiaojie Li. Overexpression of miRNA-21 Promotes the Proliferation and Invasion in Hepatocellular Carcinoma Cells via Suppressing SMAD7. Technology in Cancer Research & Treatment 2019; 18 doi: 10.1177/1533033819878686
|
| 6 |
Ahmed Sadeq Musa, Muhammad Fahmi Rizal Abdul Hadi, Nabeel Ibrahim Ashour, Nurul Ab. Aziz Hashikin. Theranostic Investigation of Gadolinium-159 for Hepatocellular Carcinoma: Monte Carlo Simulation Study. Applied Sciences 2022; 12(23): 12396 doi: 10.3390/app122312396
|
| 7 |
Shivaputra A Patil, June A Mayor, Ronald S Kaplan. Citrate Transporter Inhibitors: Possible New Anticancer Agents. Future Medicinal Chemistry 2022; 14(9): 665 doi: 10.4155/fmc-2021-0341
|
| 8 |
Jing-Huei Chen, Tsai-Hui Lin, Yu-Chuan Chien, Chung-Yu Chen, Chih-Tung Lin, Wei-Wen Kuo, Wei-Chao Chang. Aqueous Extracts of Ocimum gratissimum Sensitize Hepatocellular Carcinoma Cells to Cisplatin through BRCA1 Inhibition. International Journal of Molecular Sciences 2024; 25(15): 8424 doi: 10.3390/ijms25158424
|
| 9 |
Haiyan Jia, Hong Wang, Yanfen Yao, Chunlei Wang, Pibao Li. miR-136 Inhibits Malignant Progression of Hepatocellular Carcinoma Cells by Targeting Cyclooxygenase 2. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2018; 26(6): 967 doi: 10.3727/096504018X15148192843443
|
| 10 |
Xiaxia Pei, Jun Zhao, Zhiping Wang. Transarterial Chemoembolization Combined with Lenvatinib for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Oncology 2024; 102(8): 688 doi: 10.1159/000536006
|
| 11 |
Gui-Li Xu, Cai-Fang Ni, Han-Si Liang, Yun-Hua Xu, Wan-Sheng Wang, Jian Shen, Ming-Ming Li, Xiao-Li Zhu. Upregulation of PD-L1 expression promotes epithelial-to-mesenchymal transition in sorafenib-resistant hepatocellular carcinoma cells. Gastroenterology Report 2020; 8(5): 390 doi: 10.1093/gastro/goaa049
|
| 12 |
Elif Baris, Ayse Banu Demir. Differential effects of choline on TLR2/4 mediated signaling through possible regulation of Toll-interacting protein in hepatocellular carcinoma cell lines. Turkish Journal of Biochemistry 2024; 49(4): 551 doi: 10.1515/tjb-2023-0282
|
| 13 |
Yan-Qiong Zhang, Yan Shen, Ming-Mei Liao, Xia Mao, Gu-Jie Mi, Chen You, Qiu-Yan Guo, Wei-Jie Li, Xiao-Yue Wang, Na Lin, Thomas J. Webster. Galactosylated chitosan triptolide nanoparticles for overcoming hepatocellular carcinoma: Enhanced therapeutic efficacy, low toxicity, and validated network regulatory mechanisms. Nanomedicine: Nanotechnology, Biology and Medicine 2019; 15(1): 86 doi: 10.1016/j.nano.2018.09.002
|
| 14 |
Jeffrey M. Peters. Flipping a citrate switch on liver cancer cells. Journal of Biological Chemistry 2017; 292(33): 13902 doi: 10.1074/jbc.H117.783860
|
| 15 |
Xiaomin Ma, Yumin Qiu, Yanlin Sun, Lihui Zhu, Yunxue Zhao, Tao Li, Yueke Lin, Dapeng Ma, Zhenzhi Qin, Caiyu Sun, Lihui Han. NOD2 inhibits tumorigenesis and increases chemosensitivity of hepatocellular carcinoma by targeting AMPK pathway. Cell Death & Disease 2020; 11(3) doi: 10.1038/s41419-020-2368-5
|
| 16 |
Qianqian Zhang, Weiqian Chen, Xiuling Lv, Qiaoyou Weng, Minjiang Chen, Ri Cui, Guang Liang, Jiansong Ji. Piperlongumine, a Novel TrxR1 Inhibitor, Induces Apoptosis in Hepatocellular Carcinoma Cells by ROS-Mediated ER Stress. Frontiers in Pharmacology 2019; 10 doi: 10.3389/fphar.2019.01180
|
| 17 |
Bijay Dhungel, Charmaine A. Ramlogan-Steel, Christopher J. Layton, Jason C. Steel. miRNA122a regulation of gene therapy vectors targeting hepatocellular cancer stem cells. Oncotarget 2018; 9(34): 23577 doi: 10.18632/oncotarget.25280
|
| 18 |
Meili Gao, Chun Deng, Fan Dang. Synergistic antitumor effect of resveratrol and sorafenib on hepatocellular carcinoma through PKA/AMPK/eEF2K pathway. Food & Nutrition Research 2021; 65 doi: 10.29219/fnr.v65.3602
|
| 19 |
Jinghua Lu, Yipei Ding, Wanqiu Zhang, Yuanyuan Qi, Jin Zhou, Naihan Xu, Yaou Zhang, Weidong Xie. SQSTM1/p62 Knockout by Using the CRISPR/Cas9 System Inhibits Migration and Invasion of Hepatocellular Carcinoma. Cells 2023; 12(9): 1238 doi: 10.3390/cells12091238
|
| 20 |
Yating Xu, Xiao Yu, Zongzong Sun, Yuting He, Wenzhi Guo. Roles of lncRNAs Mediating Wnt/β-Catenin Signaling in HCC. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.831366
|
| 21 |
Ji Ah Lee, Hei-Gwon Choi, Hyuk Soo Eun, Jiyoon Bu, Tae Min Jang, Jeongdong Lee, Chae Yeon Son, Min Seok Kim, Woo Sun Rou, Seok Hyun Kim, Byung Seok Lee, Ha Neul Kim, Tae Hee Lee, Hong Jae Jeon. Programmed Death 1 and Cytotoxic T-Lymphocyte-Associated Protein 4 Gene Expression in Peripheral Blood Mononuclear Cells Can Serve as Prognostic Biomarkers for Hepatocellular Carcinoma. Cancers 2024; 16(8): 1493 doi: 10.3390/cancers16081493
|
| 22 |
Junhui Sun, Guanhui Zhou, Yuelin Zhang, Tanyang Zhou, Chunhui Nie, Tongyin Zhu, Shengqun Chen, Baoquan Wang, Ziniu Yu, Hongliang Wang, Xinhua Chen, Liangjie Hong, Liming Chen, Weilin Wang, Shusen Zheng. Comprehensive analysis of common safety profiles and their predictive factors in 520 records of liver cancer patients treated by drug-eluting beads transarterial chemoembolization. Medicine 2018; 97(26): e11131 doi: 10.1097/MD.0000000000011131
|
| 23 |
Eva Schaller, Andi Ma, Lisa Chiara Gosch, Adrian Klefenz, David Schaller, Nils Goehringer, Leonard Kaps, Detlef Schuppan, Andrea Volkamer, Rainer Schobert, Bernhard Biersack, Bianca Nitzsche, Michael Höpfner. New 3-Aryl-2-(2-thienyl)acrylonitriles with High Activity Against Hepatoma Cells. International Journal of Molecular Sciences 2021; 22(5): 2243 doi: 10.3390/ijms22052243
|
| 24 |
Chunye Zhang, Ming Yang, Aaron C. Ericsson. The Potential Gut Microbiota-Mediated Treatment Options for Liver Cancer. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.524205
|
| 25 |
Efficacy and Safety Results from a Phase 2, Randomized, Double-Blind Study of Enzalutamide Versus Placebo in Advanced Hepatocellular Carcinoma. Clinical Drug Investigation 2021; 41(9): 795 doi: 10.1007/s40261-021-01063-0
|
| 26 |
Christoph Eilenberger, Mario Rothbauer, Eva-Kathrin Ehmoser, Peter Ertl, Seta Küpcü. Effect of Spheroidal Age on Sorafenib Diffusivity and Toxicity in a 3D HepG2 Spheroid Model. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-41273-3
|
| 27 |
Teresa Faranda, Ilaria Grossi, Michele Manganelli, Eleonora Marchina, Gianluca Baiocchi, Nazario Portolani, Marialuisa Crosatti, Giuseppina De Petro, Alessandro Salvi. Differential expression profiling of long non-coding RNA GAS5 and miR-126-3p in human cancer cells in response to sorafenib. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-45604-2
|
| 28 |
Jordan W. Conway, Jorja Braden, Serigne N. Lo, Richard A. Scolyer, Matteo S. Carlino, Alexander M. Menzies, Georgina V. Long, Ines Pires da Silva. VEGF Inhibitors Improve Survival Outcomes in Patients with Liver Metastases across Cancer Types—A Meta-Analysis. Cancers 2023; 15(20): 5012 doi: 10.3390/cancers15205012
|
| 29 |
Xiaoxiao He, Zaozao Huang, Ping Liu, Qiuting Li, Mengmeng Wang, Mengjun Qiu, Zhifan Xiong, Shengli Yang. Apatinib Inhibits the Invasion and Metastasis of Liver Cancer Cells by Downregulating MMP-Related Proteins via Regulation of the NF-κB Signaling Pathway. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/3126182
|
| 30 |
Ndumiso Vukile Mdlovu, Kuen-Song Lin, Meng-Tzu Weng, Chun-Ming Wu, Sat Septian Dwitya, You-Sheng Lin. Preparation of stimuli-responsive mesoporous composites for in-vitro/in-vivo studies against liver cancer. Journal of Industrial and Engineering Chemistry 2024; 135: 444 doi: 10.1016/j.jiec.2024.01.056
|
| 31 |
Zhen Tao, Hailong Ruan, Lin Sun, Dong Kuang, Yongchun Song, Qi Wang, Tao Wang, Yi Hao, Ke Chen. Targeting the YB-1/PD-L1 Axis to Enhance Chemotherapy and Antitumor Immunity. Cancer Immunology Research 2019; 7(7): 1135 doi: 10.1158/2326-6066.CIR-18-0648
|
| 32 |
Mingxia Lu, Zhenghua Fei, Ganlu Zhang. Synergistic anticancer activity of 20(S)-Ginsenoside Rg3 and Sorafenib in hepatocellular carcinoma by modulating PTEN/Akt signaling pathway. Biomedicine & Pharmacotherapy 2018; 97: 1282 doi: 10.1016/j.biopha.2017.11.006
|
| 33 |
Bijay Dhungel, Charmaine A. Ramlogan-Steel, Jason C. Steel. Synergistic and independent action of endogenous microRNAs 122a and 199a for post-transcriptional liver detargeting of gene vectors. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-33801-4
|
| 34 |
Hongliang Zang, Yuhui Li, Xue Zhang, Guomin Huang. <p>Circ_0000517 Contributes to Hepatocellular Carcinoma Progression by Upregulating TXNDC5 via Sponging miR-1296-5p</p>. Cancer Management and Research 2020; : 3457 doi: 10.2147/CMAR.S244024
|
| 35 |
Suqin Shen, Huan Feng, Longjiang Liu, Wei Su, Long Yu, Jiaxue Wu. TCP10L negatively regulates alpha-fetoprotein expression in hepatocellular carcinoma. BMB Reports 2020; 53(8): 431 doi: 10.5483/BMBRep.2020.53.8.008
|
| 36 |
Chi-Yuan Chen, Chin-Chuan Chen, Wen-Yu Chuang, Yann-Lii Leu, Shir-Hwa Ueng, Chuen Hsueh, Chau-Ting Yeh, Tong-Hong Wang. Hydroxygenkwanin Inhibits Class I HDAC Expression and Synergistically Enhances the Antitumor Activity of Sorafenib in Liver Cancer Cells. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.00216
|
| 37 |
Payal Deepak, Rajinikanth Siddalingam, Praveen Kumar, Sneha Anand, Sunita Thakur, Balasubramaniam Jagdish, Shweta Jaiswal. Gene based nanocarrier delivery for the treatment of hepatocellular carcinoma. Journal of Drug Delivery Science and Technology 2020; 59: 101837 doi: 10.1016/j.jddst.2020.101837
|
| 38 |
Maen Abdelrahim, Abdullah Esmail, Ashish Saharia, Ala Abudayyeh, Noha Abdel-Wahab, Adi Diab, Naoka Murakami, Ahmed O. Kaseb, Jenny C. Chang, Ahmed Osama Gaber, Rafik Mark Ghobrial. Utilization of Immunotherapy for the Treatment of Hepatocellular Carcinoma in the Peri-Transplant Setting: Transplant Oncology View. Cancers 2022; 14(7): 1760 doi: 10.3390/cancers14071760
|
| 39 |
Khalil Hajiasgharzadeh, Mohammad Hossein Somi, Dariush Shanehbandi, Ahad Mokhtarzadeh, Behzad Baradaran. Small interfering RNA–mediated gene suppression as a therapeutic intervention in hepatocellular carcinoma. Journal of Cellular Physiology 2019; 234(4): 3263 doi: 10.1002/jcp.27015
|
| 40 |
Tassaya Buranupakorn, Phaviga Thangsuk, Jayanton Patumanond, Phichayut Phinyo. Emulation of a Target Trial to Evaluate the Causal Effect of Palliative Care Consultation on the Survival Time of Patients with Hepatocellular Carcinoma. Cancers 2021; 13(5): 992 doi: 10.3390/cancers13050992
|
| 41 |
Jian Pu, Jianchu Wang, Wenchuan Li, Yuan Lu, Xianjian Wu, Xidai Long, Chunying Luo, Huamei Wei. hsa_circ_0000092 promotes hepatocellular carcinoma progression through up‐regulating HN1 expression by binding to microRNA‐338‐3p. Journal of Cellular and Molecular Medicine 2024; 28(6) doi: 10.1111/jcmm.15010
|
| 42 |
Yantao Mao, Zhigang Ding, Maozhu Jiang, Bo Yuan, Yao Zhang, Xiaobin Zhang. Circ_0091579 exerts an oncogenic role in hepatocellular carcinoma via mediating miR-136-5p/TRIM27. Biomedical Journal 2022; 45(6): 883 doi: 10.1016/j.bj.2021.12.009
|
| 43 |
Xiao-xiao He, Liang-liang Shi, Meng-jun Qiu, Qiu-ting Li, Meng-meng Wang, Zhi-fan Xiong, Sheng-li Yang. Molecularly targeted anti-cancer drugs inhibit the invasion and metastasis of hepatocellular carcinoma by regulating the expression of MMP and TIMP gene families. Biochemical and Biophysical Research Communications 2018; 504(4): 878 doi: 10.1016/j.bbrc.2018.08.203
|
| 44 |
Ye Shen, Juanjie Huang, Lei Jia, Chi Zhang, Jianxing Xu. Bioinformatics and machine learning driven key genes screening for hepatocellular carcinoma. Biochemistry and Biophysics Reports 2024; 37: 101587 doi: 10.1016/j.bbrep.2023.101587
|
| 45 |
Xiaojing Zhang, Tong Liu, Yidan Zhang, Fanye Liu, Haiying Li, Dong Fang, Chaojie Wang, Hua Sun, Songqiang Xie. Elucidation of the Differences in Cinobufotalin’s Pharmacokinetics Between Normal and Diethylnitrosamine-Injured Rats: The Role of P-Glycoprotein. Frontiers in Pharmacology 2019; 10 doi: 10.3389/fphar.2019.00521
|
| 46 |
Xing Jin, Yuting Wang, Jing Chen, Miaomiao Niu, Yang Yang, Qiaoxuan Zhang, Guangyu Bao.
Novel dual-targeting inhibitors of NSD2 and HDAC2 for the treatment of liver cancer: structure-based virtual screening, molecular dynamics simulation, and
in vitro
and
in vivo
biological activity evaluations
. Journal of Enzyme Inhibition and Medicinal Chemistry 2024; 39(1) doi: 10.1080/14756366.2023.2289355
|
| 47 |
Jing Jiang, Fuguo Han, Kaixuan Cai, Qiushuo Shen, Cuiping Yang, Anli Gao, Juan Yu, Xuemei Fan, Yanli Hao, Zhao Wang, Weiping Liu, Yun Shi, Qingfei Liu. Synthesis and biological evaluation of cholic acid-conjugated oxaliplatin as a new prodrug for liver cancer. Journal of Inorganic Biochemistry 2023; 243: 112200 doi: 10.1016/j.jinorgbio.2023.112200
|
| 48 |
Yuhui Li, Hongliang Zang, Xue Zhang, Guomin Huang. <p>Exosomal Circ-ZNF652 Promotes Cell Proliferation, Migration, Invasion and Glycolysis in Hepatocellular Carcinoma via miR-29a-3p/GUCD1 Axis</p>. Cancer Management and Research 2020; : 7739 doi: 10.2147/CMAR.S259424
|